100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Lecture notes Neuropsychology & psychiatric disorders (PSMNB-3) $6.15   Add to cart

Class notes

Lecture notes Neuropsychology & psychiatric disorders (PSMNB-3)

 10 views  1 purchase
  • Course
  • Institution

These are the complete lecture notes of all 7 lectures of the course 'Neuropsychology and psychiatric disorders'.

Preview 3 out of 22  pages

  • October 29, 2022
  • 22
  • 2022/2023
  • Class notes
  • -
  • All classes
avatar-seller
Lecture slides

Lecture 1: introduction

Settings neuropsychologist:
 General hospital
 School
 Mental health care organisation
 Nursing homes

Historical perspective on psychiatry
o Before 1800 patients in institutions, no doctors involved
o 1790s French revolution (Pinel), moral treatment (psychotherapy)
o 1860s German universities start researching psychiatry, disorders were recognised as
biological disorders with involvement of the brain (linking brain to behaviour)
o 1890s Classification Kraepelin (basis for DSM)

o 1880s Hypnosis/Catharsis (Janet)  back to childhood trauma, important predictor
of psychiatric disorders in later life
o 1890s Freud’s psychoanalysis
o 1900s biological psychiatry (ECT, Lobotomy)
o 1940s Psychopharmaca (chloorpromazine: first antipsychotic drugs): ‘proof for brain
dysfunction’
o 1950s Introduction DSM
o 1960s neuropsychology in psychiatry (e.g., schizophrenia

Modern psychiatry
 brain (body) X environment interaction, for example trauma (environment)
influences the body (brain)
 recovery beyond symptomatic remission  e.g., focus on quality of life, participation
in society
 the combination of psychosocial and pharmacological treatments (however, reduce
medication as soon as possible)
 2013 DSM 5 (categorisation)
 NIMH RDoC (biological disorders)

Goal of NIMH RDoC: understanding the nature of mental health and illness in terms of
varying degrees of dysfunction in fundamental psychological/biological systems. This is to
provide a different way of thinking about mental disorders without focussing on the label.
This framework is developed for research. When using labels, there is a lot of comorbidity.

Definitions:
 psychiatry: medical specialty concerned with the diagnosis and treatment of mental
illness.
 neurology: medical specialty concerned with the diagnosis and treatment of
disorders of the nervous system (brain, spinal cord and nerves).

,  Neuropsychology: psychological speciality concerned with the relationship between
behaviour, emotion and cognition on the one hand, and brain function on the other.


Traditional neuropsychology
 assessment traditionally focusses on determining specific changes in mental
processes after discrete brain lesions
 helped to determine locus of lesion
 knowledge on the role of brain areas in mental processes
 focus on neurological patients

How we see ourselves
 generating hypotheses on underlying mechanisms of symptoms
 understanding the role of cognitive processes in the etiology and presentation of
psychiatric disorders (biomedical model)
 understanding the clinical, behavioural, and phenomenological correlates of
‘neuropsychological impairments’
 doing individual neuropsychological assessments (profile of strengths and
weaknesses)

How psychiatrists see us
 useful but underutilised resource
 establishing deterioration in cognitive functioning
 making differential diagnosis (however, not really true because there is a lot of
heterogeneity and not every schizophrenic has the same brain activity etc.)
 facilitating improved outcomes
 psychiatrists need to recognise cognitive impairments and to understand common
neuropsychological tests

Interpretation errors in neuropsychiatry
 Neuropsychological tests measure specific functions, and poor performance on a
single test indicates a specific neuropsychological deficit
 abnormal neuropsychological test performance indicates specific regional brain
dysfunction
 ‘hypoactivity’ during functional imaging procedures with cognitive activation tasks
suggests regional brain dysfunction

Therapy
 cognitive remediation: training people to overcome their cognitive impairments
 neuropsychological test data can be used to develop treatment strategies tailored
for an individual’s specific cognitive strengths and deficits (‘rate limiting factors’)




Lecture 2: schizophrenia

, DSM-5 criteria:
A. two (or more) of the following:
1. delusions
2. hallucinations
3. disorganised speech
4. grossly disorganised or catatonic behaviour
5. negative symptoms
etc.

The content of delusions and hallucinations differs between cultures.
Many with psychotic disorders have poor insight.

Using symptom dimensions helps you pick your treatment targets.

Schizophrenia/psychotic symptoms appears in late adolescence or early adulthood (18-25).

Apart from classification, psychotic disorders can also be thought of in clinical stages
(severity). Treatment should be targeted to the specific stage of the disorder.

Treatment is also about normalising the symptoms instead of trying to get rid of them.
Some even like the voices they hear.

Psychological treatments according to clinical guidelines
 standard:
o psycho-education
o family interventions
o cognitive behavioural therapy (CBT)
 optional (examples):
o cognitive remediation
o rTMS

There is no such thing as a cognitive profile for psychotic disorders. There is a wide range of
cognitive functions that are affected. Moreover, cognitive deficits cannot be explained by
the presence of hallucinations, delusions, or apathy. A proportion of patients with
schizophrenia appear to remain neuropsychologically intact.
The cognitive impairments are not due to medication.

Overall, all the developmental milestones are achieved later in those with schizophrenia.

With every stage in the disorder, the cognitive impairments tend to increase. In earlier
writing, it was believed that there is intellectual decline. For example, the term ‘dementia
praecox’ implies a continuing cognitive decline. However, this is not true. After the initial
drop of cognitive decline around first onset, there is stabilisation or even improvement. We
can’t say that this is a progressive illness.
 following the onset of the first psychotic episode, most patients experience a substantial
decline in cognitive functions compared to their premorbid level. Most cognitive deficits

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Astridtos. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $6.15. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

83662 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$6.15  1x  sold
  • (0)
  Add to cart